The vitamins and minerals based injectables market is projected to grow from USD 6.5 billion in 2026 to USD 13.5 billion by 2036, at a CAGR of 7.6%. Multivitamin injectable formulations will dominate with a 42.0% market share, while nutritional deficiencies will lead the indication segment with a 45.0% share.